Bennett Selby Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Buy
645
+8
+1% +$2.74K 0.07% 77
2026
Q1
$224K Hold
637
0.08% 77
2025
Q4
$208K Buy
+637
New +$202K 0.07% 83
2024
Q4
Sell
-654
Closed -$211K 75
2024
Q3
$211K Hold
654
0.09% 74
2024
Q2
$204K Buy
+654
New +$192K 0.09% 70

Other funds holding AMGN

Bennett Selby Investments's AMGN Position: Q2 2026 in Review

Bennett Selby Investments increased its Amgen (AMGN) stake by 1.3% in Q2 2026, buying an estimated $2.74K and bringing the position to 645 shares worth $234K. The position accounts for 0.07% of the portfolio, ranked #77.

Bennett Selby Investments first reported a position in AMGN in Q2 2024 and has held it in 5 quarters since. 1,709 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bennett Selby Investments held 645 shares of Amgen worth $234K as of Q2 2026.
  • Bennett Selby Investments bought 8 Amgen shares in Q2 2026, an estimated $2.74K.
  • Amgen made up 0.07% of Bennett Selby Investments's portfolio in Q2 2026, its #77 holding.
  • Bennett Selby Investments first reported a position in Amgen in Q2 2024 and has held it in 5 quarters since.
  • 1,709 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bennett Selby Investments's 13F filing for Q2 2026, filed 24 Jul 2026.